T-cadherin Is Essential for Adiponectin-mediated Revascularization*

Background: Adiponectin has vascular protective actions and is bound by T-cadherin. Results: T-cadherin-deficient mice lack skeletal muscle tissue-resident adiponectin and display impaired revascularization that is not improved by treatment with exogenous adiponectin. Conclusion: Expression of T-cadherin is critical for revascularization actions of adiponectin in vitro and in vivo. Significance: The T-cadherin/adiponectin interaction is important for vascular homeostasis. Adipose tissue secretes protein factors that have systemic actions on cardiovascular tissues. Previous studies have shown that ablation of the adipocyte-secreted protein adiponectin leads to endothelial dysfunction, whereas its overexpression promotes wound healing. However, the receptor(s) mediating the protective effects of adiponectin on the vasculature is not known. Here we examined the role of membrane protein T-cadherin, which localizes adiponectin to the vascular endothelium, in the revascularization response to chronic ischemia. T-cadherin-deficient mice were analyzed in a model of hind limb ischemia where blood flow is surgically disrupted in one limb and recovery is monitored over 28 days by laser Doppler perfusion imaging. In this model, T-cadherin-deficient mice phenocopy adiponectin-deficient mice such that both strains display an impaired blood flow recovery compared with wild-type controls. Delivery of exogenous adiponectin rescued the impaired revascularization phenotype in adiponectin-deficient mice but not in T-cadherin-deficient mice. In cultured endothelial cells, T-cadherin deficiency by siRNA knockdown prevented the ability of adiponectin to promote cellular migration and proliferation. These data highlight a previously unrecognized role for T-cadherin in limb revascularization and show that it is essential for mediating the vascular actions of adiponectin.

[1]  R. Klemenz,et al.  Advances in Brief Increased Expression of H/T-Cadherin in Tumor-penetrating Blood Vessels 1 , 2022 .

[2]  S. Kihara,et al.  Adiponectin Promotes Revascularization of Ischemic Muscle through a Cyclooxygenase 2-Dependent Mechanism , 2009, Molecular and Cellular Biology.

[3]  J. Isner,et al.  Mouse model of angiogenesis. , 1998, The American journal of pathology.

[4]  Jeroen J. Bax,et al.  A decline in walking distance predicts long-term outcome in patients with known or suspected peripheral artery disease , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[5]  H. Yoshiji,et al.  Crosstalk between high-molecular-weight adiponectin and T-cadherin during liver fibrosis development in rats. , 2007, International journal of molecular medicine.

[6]  H. Lodish,et al.  T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[8]  N. Turner,et al.  Overexpression of the Adiponectin Receptor AdipoR1 in Rat Skeletal Muscle Amplifies Local Insulin Sensitivity , 2012, Endocrinology.

[9]  S. Kihara,et al.  Adiponectin Stimulates Angiogenesis in Response to Tissue Ischemia through Stimulation of AMP-activated Protein Kinase Signaling* , 2004, Journal of Biological Chemistry.

[10]  M. Bohlooly-y,et al.  Opposing Effects of Adiponectin Receptors 1 and 2 on Energy Metabolism , 2007, Diabetes.

[11]  C. Nishitani,et al.  Diverse Functions of Pulmonary Collectins in Host Defense of the Lung , 2012, Journal of biomedicine & biotechnology.

[12]  M. Philippova,et al.  Identification of an atypical lipoprotein‐binding protein from human aortic smooth muscle as T‐cadherin , 1998, FEBS letters.

[13]  R. Cardiff,et al.  T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. , 2008, Cancer research.

[14]  A. Andreeva,et al.  Cadherin 13 in cancer , 2010, Genes, chromosomes & cancer.

[15]  R. Collins,et al.  Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies , 2009, The Lancet.

[16]  NoriyukiOuchi,et al.  Adiponectin Suppresses Pathological Microvessel Formation in Retina Through Modulation of Tumor Necrosis Factor-α Expression , 2009 .

[17]  L. Campbell,et al.  Human adiponectin binds to bacterial lipopolysaccharide. , 2006, Biochemical and biophysical research communications.

[18]  P. Erne,et al.  Expression of cell adhesion molecule T-cadherin in the human vasculature , 2001, Histochemistry and Cell Biology.

[19]  P. Quax,et al.  Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. , 2008, Annals of vascular surgery.

[20]  S. Kihara,et al.  Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. , 2007, The Journal of clinical investigation.

[21]  P. Erne,et al.  Atypical GPI-Anchored T-Cadherin Stimulates Angiogenesis In Vitro and In Vivo , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[22]  K. Walsh,et al.  Adiponectin and cardiovascular inflammatory responses , 2007, Current atherosclerosis reports.

[23]  B. Ranscht,et al.  T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region , 1991, Neuron.

[24]  M. Montagnana,et al.  A variant upstream of the CDH13 adiponectin receptor gene and metabolic syndrome in Swedes. , 2011, The American journal of cardiology.

[25]  P. Erne,et al.  Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3beta in endothelial cells. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  P. Erne,et al.  Identification of Proteins Associating with Glycosylphosphatidylinositol- Anchored T-Cadherin on the Surface of Vascular Endothelial Cells: Role for Grp78/BiP in T-Cadherin-Dependent Cell Survival , 2008, Molecular and Cellular Biology.

[27]  M. Bronner‐Fraser,et al.  T-cadherin expression alternates with migrating neural crest cells in the trunk of the avian embryo. , 1991, Development.

[28]  P. Erne,et al.  LDL induces intracellular signalling and cell migration via atypical LDL-binding protein T-cadherin , 2005, Molecular and Cellular Biochemistry.

[29]  M. Birnbaum,et al.  Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin , 2011, Nature Medicine.

[30]  Ivan Martin,et al.  Use of multicellular tumor spheroids to dissect endothelial cell–tumor cell interactions: A role for T‐cadherin in tumor angiogenesis , 2007, FEBS letters.

[31]  Wen-Harn Pan,et al.  A Genome-Wide Association Study Reveals a Quantitative Trait Locus of Adiponectin on CDH13 That Predicts Cardiometabolic Outcomes , 2011, Diabetes.

[32]  Christian Gieger,et al.  Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations , 2009, Human molecular genetics.

[33]  P. Erne,et al.  T-cadherin attenuates insulin-dependent signalling, eNOS activation, and angiogenesis in vascular endothelial cells. , 2012, Cardiovascular research.

[34]  S. Kash,et al.  Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes. , 2007, Endocrinology.

[35]  Yun Li,et al.  Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. , 2010, Human molecular genetics.

[36]  J. Pollard,et al.  Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo , 2009, Clinical Cancer Research.

[37]  J. Martínez,et al.  The − 11391 G/A Polymorphism of the Adiponectin Gene Promoter is Associated with Metabolic Syndrome Traits and the Outcome of an Energy-restricted Diet in Obese Subjects , 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[38]  S. Kihara,et al.  Adiponectin-mediated modulation of hypertrophic signals in the heart , 2004, Nature Medicine.

[39]  P. Froguel,et al.  Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.

[40]  R. Sacco,et al.  Genetic loci for blood lipid levels identified by linkage and association analyses in Caribbean Hispanics[S] , 2011, Journal of Lipid Research.

[41]  V. Cachofeiro,et al.  The Effects of Adiponectin and Leptin on Human Endothelial Cell Proliferation: A Live-Cell Study , 2012, Journal of Vascular Research.

[42]  P. Erne,et al.  T-cadherin upregulation correlates with cell-cycle progression and promotes proliferation of vascular cells. , 2004, Cardiovascular research.

[43]  S. Kihara,et al.  Adiponectin Suppresses Pathological Microvessel Formation in Retina Through Modulation of Tumor Necrosis Factor-α Expression , 2009, Circulation Research.

[44]  Y. Kokubo,et al.  CDH13 gene coding t‐cadherin influences variations in plasma adiponectin levels in the Japanese population , 2012, Human mutation.

[45]  Y. Hayashi,et al.  Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+ and AMPK/SIRT1 , 2010, Nature.

[46]  S. Kihara,et al.  Adiponectin Stimulates Angiogenesis by Promoting Cross-talk between AMP-activated Protein Kinase and Akt Signaling in Endothelial Cells* , 2004, Journal of Biological Chemistry.

[47]  Yasser Khalil,et al.  The Relationship of Peripheral Arterial Disease and Metabolic Syndrome Prevalence in Asymptomatic US Adults 40 Years and Older: Results From the National Health and Nutrition Examination Survey (1999–2004) , 2012, Journal of clinical hypertension.

[48]  K. Walsh,et al.  Adipokines in inflammation and metabolic disease , 2011, Nature Reviews Immunology.

[49]  N. Cook,et al.  High-Molecular-Weight and Total Adiponectin Levels and Incident Symptomatic Peripheral Artery Disease in Women: A Prospective Investigation , 2011, Circulation.

[50]  T. Beaty,et al.  Adiponectin concentrations: a genome-wide association study. , 2010, American journal of human genetics.

[51]  K. Walsh,et al.  Targeting adiponectin for cardioprotection , 2006, Expert opinion on therapeutic targets.

[52]  R. Cardiff,et al.  Adiponectin Deficiency Limits Tumor Vascularization in the MMTV-PyV-mT Mouse Model of Mammary Cancer , 2009, Clinical Cancer Research.

[53]  M. Philippova,et al.  T‐cadherin and signal‐transducing molecules co‐localize in caveolin‐rich membrane domains of vascular smooth muscle cells , 1998, FEBS letters.

[54]  P. Erne,et al.  Extracellular Cadherin repeat domains EC1 and EC5 of T‐cadherin are essential for its ability to stimulate angiogenic behavior of endothelial cells , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  Yajing Wang,et al.  AMP-Activated Protein Kinase Deficiency Enhances Myocardial Ischemia/Reperfusion Injury but Has Minimal Effect on the Antioxidant/Antinitrative Protection of Adiponectin , 2009, Circulation.

[56]  S. Kihara,et al.  Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms , 2005, Nature Medicine.

[57]  H. Randeva,et al.  Protective Actions of Globular and Full-Length Adiponectin on Human Endothelial Cells: Novel Insights into Adiponectin-Induced Angiogenesis , 2012, Journal of Vascular Research.

[58]  S. Kihara,et al.  Adiponectin promotes endothelial progenitor cell number and function , 2008, FEBS Letters.

[59]  H. Tiwari,et al.  Preliminary evidence of genetic determinants of adiponectin response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[60]  R J Hinchliffe,et al.  Diagnosis and management of peripheral arterial disease , 2012, BMJ : British Medical Journal.

[61]  S. Jee,et al.  Effects of Smoking and Obesity on the Association Between CDH13 (rs3865188) and Adiponectin Among Korean Men: The KARE Study , 2012, Obesity.

[62]  B. Tyrberg,et al.  T-cadherin (Cdh13) in association with pancreatic β-cell granules contributes to second phase insulin secretion , 2011, Islets.

[63]  Dexi Liu,et al.  Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA , 1999, Gene Therapy.

[64]  P. Ruiz-Lozano,et al.  T-cadherin is critical for adiponectin-mediated cardioprotection in mice. , 2010, The Journal of clinical investigation.

[65]  David G. Wilkinson,et al.  T-cadherin suppresses angiogenesis in vivo by inhibiting migration of endothelial cells , 2007, Angiogenesis.

[66]  P. Erne,et al.  Integrin‐linked kinase is an essential mediator for T‐cadherin‐dependent signaling via Akt and GSK3β in endothelial cells , 2007 .

[67]  T. Voyno-Yasenetskaya,et al.  T-cadherin is located in the nucleus and centrosomes in endothelial cells. , 2009, American journal of physiology. Cell physiology.